Validation of [11C]ORM-13070 as a PET tracer for alpha2c-adrenoceptors in the human brain-Reference-Cited by-同舟云学术

Validation of [11C]ORM-13070 as a PET tracer for alpha2c-adrenoceptors in the human brain

Published:2015-01-08 Issue:3 Volume:69 Page:172-181
ISSN:0887-4476
Container-title:Synapse
language:en
Short-container-title:Synapse

Author:

Lehto Jussi¹²³,Hirvonen Mika M.²,Johansson Jarkko⁴,Kemppainen Jukka⁴⁵,Luoto Pauliina⁴,Naukkarinen Tarja⁶,Oikonen Vesa⁴,Arponen Eveliina⁴,Rouru Juha⁶,Sallinen Jukka⁶,Scheinin Harry¹⁴,Vuorilehto Lauri³,Finnema Sjoerd J.⁷,Halldin Christer⁷,Rinne Juha O.²⁴,Scheinin Mika¹²³

Affiliation:

1. Department of Pharmacology; Drug Development and Therapeutics, University of Turku; Turku Finland

2. Clinical Research Services Turku CRST; Turku Finland

3. Unit of Clinical Pharmacology; Turku University Hospital; Turku Finland

4. Turku PET Centre; University of Turku and Turku University Hospital; Turku Finland

5. Department of Clinical Physiology and Nuclear Medicine; Turku University Hospital; Turku Finland

6. Orion Corporation Orion Pharma; Turku Finland

7. Department of Clinical Neuroscience; Center for Psychiatric Research and Education; Karolinska Institute; Stockholm Sweden

Funder

Innovative Medicines Initiative

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/syn.21798/fullpdf

Reference44 articles.

1. Ketamine does not decrease striatal dopamine D2 receptor binding in man;Aalto;Psychopharmacology (Berl),2002

2. Comparison of regional cerebral blood flow responses to hypoglycemia using pulsed arterial spin labeling and positron emission tomography;Arbeláez;PLoS One,2013

3. A PET tracer for brain alpha2C adrenoceptors, 11C-ORM-13070: Radiosynthesis and preclinical evaluation in rats and knockout mice;Arponen;J Nucl Med,2014

4. Atomoxetine: The first nonstimulant for the management of attention-deficit/hyperactivity disorder;Corman;Am J Health Syst Pharm,2004

5. Glucose clamp technique: A method for quantifying insulin secretion and resistance;DeFronzo;Am J Physiol,1979

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview: Radiotracers and nano-radiopharmaceuticals for diagnosis of Parkinson's disease;Applied Radiation and Isotopes;2024-01

2. Development and Optimization of ¹¹C-Labeled Radiotracers: A Review of the Modern Quality Control Design Process;ACS Pharmacology & Translational Science;2023-10-11

3. Preclinical evaluation of new C-11 labeled benzo-1,4-dioxane PET radiotracers for brain α2C adrenergic receptors;European Journal of Medicinal Chemistry;2022-12

4. Application of the PET ligand [11C]ORM-13070 to examine receptor occupancy by the α2C-adrenoceptor antagonist ORM-12741: translational validation of target engagement in rat and human brain;EJNMMI Research;2020-12

5. Selective adrenergic alpha2C receptor antagonist ameliorates acute phencyclidine-induced schizophrenia-like social interaction deficits in rats;Psychopharmacology;2018-12-10